Triple-Negative Breast Cancer (TNBC) Completed Phase 2 / 3 Trials for Carboplatin (DB00958)

Also known as: TNBC, Triple Negative Breast Cancer / TNBC - Triple-Negative Breast Cancer / Breast Cancer (Triple Negative Breast Cancer (TNBC)) / Breast Cancer Triple Negative / Triple Negative Breast Cancer TNBC / Triple -Negative Breast Cancer / Triple-Negative Breast Cancer / Triple Negative Breast Cancer (TNBC) / Triple Negative Breast Cancer / Triple negative breast cancer metastatic / Triple negative malignant neoplasm of breast (disorder) / Triple Negative Breast Neoplasms

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01881230Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)Treatment